PLRX

PLIANT THERAPEUTICS, INC.

PLRX · CIK 1746473 · Annual (10-K) · Last 5 years

Financial Trends

Revenue$0M
20202024
Net Income−$210M
20202024
Operating CF−$156M
20202024
Free Cash Flow−$159M
20202024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B
Cost of Revenue—————
Gross Profit—————
R&D Expense$0.2B$0.1B$0.1B$0.1B$0.1B
SG&A Expense—————
Operating Income$-0.2B$-0.2B$-0.1B$-0.1B$-0.0B
Net Income$-0.2B$-0.2B$-0.1B$-0.1B$-0.0B
EPS (Basic)$-3.47$-2.75$-2.94$-2.71$-1.95
EPS (Diluted)$-3.47$-2.75$-2.94$-2.71$-1.95

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Total Assets$0.4B$0.5B$0.4B$0.2B$0.3B
Current Assets$0.4B$0.5B$0.3B$0.2B$0.3B
Cash & Equivalents$0.1B$0.1B$0.0B$0.1B$0.1B
Total Liabilities$0.1B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.3B$0.5B$0.3B$0.2B$0.3B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Operating Cash Flow$-0.2B$-0.1B$-0.1B$-0.1B$-0.0B
Investing Cash Flow$0.1B$-0.1B$-0.2B$0.1B$-0.2B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.3B$0.2B$0.0B$0.2B
← Companies